Image

Global Pancreatic Enzyme Replacement Therapy Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

Global Pancreatic Enzyme Replacement Therapy Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Pancreatic Enzyme Replacement Therapy Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 9.30 USD Billion
Diagram Market Size (Forecast Year) USD 16.22 USD Billion
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Pancreatic Enzyme Replacement Therapy Market, By Type (Enteric Coated and Non-Enteric Coated), Treatment (Medication, Therapy), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others) – Industry Trends and Forecast to 2030.

Pancreatic Enzyme Replacement Therapy Market

Pancreatic Enzyme Replacement Therapy Market Analysis and Size

The increased prevalence of rare diseases has significantly contributed to the use of enzyme replacement therapies, and medical research is projected to accelerate this progress further. As per the estimates from Genetic Alliance U.K., a single rare disease is projected to affect over 30,000 individuals in the U.K. It has been witnessed and observed that most chronic diseases are life-threatening, and timely medical treatment is essential to reduce mortality rates. Increasing use of several pancreatic enzymes such as lipase, amylase, and protease are used for the treatment of exocrine pancreatic insufficiency (EPI), which is seen commonly in cancer patients.

Data Bridge Market Research analyses a growth rate in the pancreatic enzyme replacement therapy market in the forecast period 2023-2030. The expected CAGR of the pancreatic enzyme replacement therapy market tends to be around 7.2% in the mentioned forecast period. The market was valued at USD 9.3 billion in 2022 and would grow to USD 16.22 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Pancreatic Enzyme Replacement Therapy Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (Enteric Coated and Non-Enteric Coated), Treatment (Medication, Therapy), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Cigna (U.S.), Shire Pharmaceuticals Limited (U.S.), Sanofi (France)., BioMarin (U.S.)., Alexion Pharmaceuticals, Inc (U.S.)., AbbVie Inc. (U.S.), Horizon Therapeutics plc (U.S.), Janssen Global Services, LLC (U.S.), Recordati Rare Diseases (Italy), Protalix Biotherapeutics (Israel), Amicus Therapeutics, Inc (U.S.), Jasper Therapeutics, Inc. (U.S.)

Market Opportunities

  • Increased Clinical Trials
  • Higher Strategic Alliances

Market Definition

The pancreatic enzyme replacement therapy belongs to the type of medications that contain enzymes to replace when the pancreas can no longer release or produce enzymes naturally. These type of medications that contain proteases to digest protein, amylases to digest carbohydrates and lipases to digest fat. The food is not able to fully digest in the absence of pancreatic enzymes and all the nutrients and calories that are present in the food are not able to absorb properly and said as ‘malabsorption.’.

Global Pancreatic Enzyme Replacement Therapy Market Dynamics

Drivers

  • Prevalence of Rare Diseases

According to Genetic Alliance UK records, a single rare disease is projected to affect over 30,000 individuals in the U.K. The most commonly occurring lysosomal storage diseases include Gaucher, Pompe, Fabry, and SCID diseases. Rare diseases such as these types occur in low frequencies. For instance, according to Orphanet, Gaucher’s disease is projected to be widespread in 1 individual in over 100,000 individuals. The low incidence of rare or orphan diseases is one of the major factors for its limited growth in the pharmaceutical industry.

  • Increasing Cases of Chronic Diseases and Cancer

The growing prevalence of chronic diseases and cancer occurrence is estimated to boost the market's growth during the forecast period. For instance, according to the National Cancer Institute (NCI), in 2016, there were an estimated 15.5 million cancer cases that have been occurred in the U.S. Additionally, NCI records say that, in 2017, around 15,270 children and adolescents of the age group of 0 to 19 were diagnosed with cancer in the U.S. Furthermore, according to the International Diabetes Federation (IDF), in 2017, more than 425 million adults suffered from diabetes globally, and this is expected to reach 629 million by 2045. Thus, it boosts market growth.

Opportunities

  • Increased Pancreatic Cancer And The Use of Enzymes

Increasing use of pancreatic enzymes such as amylase, lipase, and protease are used to treat exocrine pancreatic insufficiency (EPI), which is commonly seen in cancer patients. According to the records of American Cancer Society,  over 55,440 individuals were expected to be diagnosed with pancreatic cancer in the year 2018. Increasing incidence of pancreatic cancer is thus anticipated to drive market growth during the forecast period.

Restraints/Challenges

  • Risk of Complications

There is a severe high risk of complications associated with the use fo enzyme replacement therapies. Severe Complications such as skin reactions, increased risk of blood clots, sleep apnea, and many others are witnessed post the therapy. Thus, it hampers market growth.

  • High Cost

The huge expenditure associated with gene therapies obstructs the market growth. Most pancreatic enzyme replacement therapy products are from the U.S. and are covered under reimbursement policies. Though, patients who do not have insurance find it difficult to afford such treatments.

This pancreatic enzyme replacement therapy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pancreatic enzyme replacement therapy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Global Pancreatic Enzyme Replacement Therapy Market Scope

The pancreatic enzyme replacement therapy market is segmented on the basis of type, treatment, route of administration and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Enteric Coated
  • Non-Enteric Coated

Treatment

  • Medication
  • Therapy

Route of Administration

  • Oral
  • Parenteral
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Pancreatic Enzyme Replacement Therapy Market Regional Analysis/Insights

The pancreatic enzyme replacement therapy market is analyzed and market size insights and trends are provided by type, treatment, route of administration and end-user as referenced above.

The major countries covered in the pancreatic enzyme replacement therapy market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing positive growth for the pancreatic enzyme replacement therapy market throughout the forecast period due to the presence of key manufacturers of the product, high research and development and healthcare expenditure and skilled professionals.

Asia-Pacific dominates the market due to increased technological advancement and the increasing prevalence of chronic and metabolic diseases.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Pancreatic Enzyme Replacement Therapy Market Share Analysis

The pancreatic enzyme replacement therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to pancreatic enzyme replacement therapy market

Key players operating in the pancreatic enzyme replacement therapy market include:

  • Cigna (U.S.)
  • Shire Pharmaceuticals Limited (U.S.)
  • Sanofi (France)
  • BioMarin (U.S.)
  • Alexion Pharmaceuticals, Inc (U.S.)
  • AbbVie Inc. (U.S.)
  • Horizon Therapeutics plc (U.S.)
  • Janssen Global Services, LLC (U.S.)
  • Recordati Rare Diseases (Italy)
  • Protalix Biotherapeutics (Israel)
  • Amicus Therapeutics, Inc (U.S.)
  • Jasper Therapeutics, Inc. (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Pancreatic Enzyme Replacement Therapy Market is projected to grow at a CAGR of 7.2% during the forecast period by 2030.
The future market value of the Pancreatic Enzyme Replacement Therapy Market is expected to reach USD 16.22 billion by 2030.
The major players in the Pancreatic Enzyme Replacement Therapy Market Cigna (U.S.), Shire Pharmaceuticals Limited (U.S.), Sanofi (France)., BioMarin (U.S.)., Alexion Pharmaceuticals, Inc (U.S.)., AbbVie Inc. (U.S.), Horizon Therapeutics plc (U.S.), Janssen Global Services, LLC (U.S.), etc.
The countries covered in the Pancreatic Enzyme Replacement Therapy Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, etc.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials